A Preview Of Krystal Biotech's Earnings
Portfolio Pulse from Benzinga Insights
Krystal Biotech (NASDAQ:KRYS) is scheduled to release its quarterly earnings report on February 26, 2024, with an estimated EPS of $-0.37. Despite past earnings misses, the company's stock price has historically increased following earnings announcements. Shares are currently trading at $111.96, reflecting a 42.04% increase over the last 52 weeks. Investors are optimistic but will be closely watching the company's guidance for future growth.

February 23, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Krystal Biotech is expected to announce its quarterly earnings with an anticipated EPS of $-0.37. Historical data shows positive stock price movement post-earnings, despite previous misses. Currently, shares have seen a significant 42.04% increase over the last year.
Given Krystal Biotech's history of stock price increases following earnings reports, even after missing EPS estimates, there's a positive outlook for short-term stock performance. The anticipation of future guidance, coupled with a strong year-over-year share price increase, further supports a likely positive impact.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100